Donnenfeld Discusses How New Diagnostics, Treatments Impact His Practice and Patients
[creativ_pullleft colour=”light-gray” colour_custom=”” text=”Episode 138″]
Eric Donnenfeld, MD, founding partner of OCLI, shares how his practice is incorporating new diagnostics and treatments. “I spend less time diagnosing the disease and it enables me to spend more time talking to the patients about therapies,” Dr. Donnenfeld says. He also praises Shire and Allergan for their effective marketing.
Eric Donnenfeld, MD
Eric Donnenfeld is a trustee of Dartmouth Medical School and a clinical professor of ophthalmology at NYU. He is past president of ASCRS and is in the presidential succession line for the International Intraocular Implant Society.